scispace - formally typeset
P

Peng Zhang

Researcher at Beijing University of Posts and Telecommunications

Publications -  71
Citations -  4276

Peng Zhang is an academic researcher from Beijing University of Posts and Telecommunications. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 20, co-authored 61 publications receiving 3715 citations. Previous affiliations of Peng Zhang include Xuzhou Medical College & Sichuan University.

Papers
More filters
Journal ArticleDOI

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

TL;DR: As2O3 treatment is an effective and relatively safe drug in APL patients refractory to ATRA and conventional chemotherapy, and Pharmacokinetic studies showed that after a peak level of 5.54 micromol/L, plasma arsenic was rapidly eliminated, and the continuous administration of As2O2 did not alter its pharmacokinetic behaviors.
Journal ArticleDOI

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : I. As2O3 exerts dose-dependent dual effects on APL cells

TL;DR: Combination of induction of apoptosis and partial differention could be the main cellular mechanisms of As2O3 in the treatment of APL, and PML-RAR alpha could play an important role in determining the specific effects of As 2O3 on APL cells.
Journal ArticleDOI

β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice.

TL;DR: The data suggest that elevating consumption of β-glucan-rich foods is an easily implementable nutritional strategy to alleviate detrimental features of gut-brain dysregulation and prevent neurodegenerative diseases associated with Westernized dietary patterns.
Journal ArticleDOI

Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.

TL;DR: The progress in miRNA-related research, including study of its oncogene or tumour-suppressor roles and the advantages of miRNA biomarkers for CRC diagnosis, treatment and recurrence prediction are summarized.